User profiles for Antonio Bellasi
Antonio Bellasi, MD PhDEnte Ospedaliero Cantonale (EOC), Lugano, Switzerland Verified email at eoc.ch Cited by 8683 |
Mortality in kidney disease patients treated with phosphate binders: a randomized study
B Di Iorio, A Bellasi, D Russo… - Clinical Journal of the …, 2012 - journals.lww.com
Results In patients randomized to sevelamer, all-cause mortality and the composite end
point were lower; a nonsignificant trend was noted for dialysis inception. Conclusions …
point were lower; a nonsignificant trend was noted for dialysis inception. Conclusions …
Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation
…, A Rossini, PA Bonaffini, G Guerra, A Bellasi… - Epidemiology & …, 2021 - cambridge.org
Bergamo province was badly hit by the coronavirus disease 2019 (COVID-19) epidemic. We
organised a public-funded, multidisciplinary follow-up programme for COVID-19 patients …
organised a public-funded, multidisciplinary follow-up programme for COVID-19 patients …
International electronic health record-derived COVID-19 clinical course profiles: the 4CE consortium
We leveraged the largely untapped resource of electronic health record data to address critical
clinical and epidemiological questions about Coronavirus Disease 2019 (COVID-19). To …
clinical and epidemiological questions about Coronavirus Disease 2019 (COVID-19). To …
Cardiorenal syndrome: an overview
It is well established that a large number of patients with acute decompensated heart failure
present with various degrees of heart and kidney dysfunction usually primary disease of …
present with various degrees of heart and kidney dysfunction usually primary disease of …
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID‐19. Results of the Cardio‐COVID‐Italy multicentre study
…, P Ameri, L Barbieri, A Bellasi… - European journal of …, 2020 - Wiley Online Library
Aims To assess the prognostic value of a history of heart failure (HF) in patients with coronavirus
disease 2019 (COVID‐19). Methods and results We enrolled 692 consecutive patients …
disease 2019 (COVID‐19). Methods and results We enrolled 692 consecutive patients …
Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial
…, E Cucciniello, V Bellizzi, D Russo, A Bellasi… - American Journal of …, 2013 - Elsevier
Background Whether the use of sevelamer rather than a calcium-containing phosphate
binder improves cardiovascular (CV) survival in patients receiving dialysis remains to be …
binder improves cardiovascular (CV) survival in patients receiving dialysis remains to be …
Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction
A Bellasi, M Mandreoli, L Baldrati… - Clinical Journal of the …, 2011 - journals.lww.com
Results Older age and male sex were associated with lower phosphate levels. Instead,
higher phosphate levels were noted in patients with diabetes. Patients with phosphate levels≥ …
higher phosphate levels were noted in patients with diabetes. Patients with phosphate levels≥ …
Association of troponin levels with mortality in Italian patients hospitalized with coronavirus disease 2019: results of a multicenter study
…, V Carubelli, A Iorio, RM Inciardi, A Bellasi… - JAMA …, 2020 - jamanetwork.com
Importance Myocardial injury, detected by elevated plasma troponin levels, has been
associated with mortality in patients hospitalized with coronavirus disease 2019 (COVID-19). …
associated with mortality in patients hospitalized with coronavirus disease 2019 (COVID-19). …
All-cause mortality in hemodialysis patients with heart valve calcification
Results Overall, 38.2% of patients had mitral VC and 44.4% had aortic VC on
echocardiography. Patients with VC were older and less likely to be African American; all other …
echocardiography. Patients with VC were older and less likely to be African American; all other …
Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study
Background Metabolic acidosis is associated with accelerated progression of chronic kidney
disease (CKD). Whether treatment of metabolic acidosis with sodium bicarbonate improves …
disease (CKD). Whether treatment of metabolic acidosis with sodium bicarbonate improves …